T. Rowe Price Associates’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $273K | Buy |
26,705
+3,800
| +17% | +$41K | ﹤0.01% | 2727 |
|
|
2025
Q4 | $245K | Buy |
22,905
+4,500
| +24% | +$53.8K | ﹤0.01% | 2736 |
|
|
2025
Q3 | $252K | Buy |
18,405
+3,612
| +24% | +$50.5K | ﹤0.01% | 2694 |
|
|
2025
Q2 | $208K | Buy |
14,793
+520
| +4% | +$6.83K | ﹤0.01% | 2697 |
|
|
2025
Q1 | $193K | Buy |
14,273
+2,891
| +25% | +$43.4K | ﹤0.01% | 2658 |
|
|
2024
Q4 | $201K | Sell |
11,382
-6,496
| -36% | -$121K | ﹤0.01% | 2678 |
|
|
2024
Q3 | $343K | Buy |
17,878
+67
| +0.4% | +$1.29K | ﹤0.01% | 2415 |
|
|
2024
Q2 | $389K | Buy |
17,811
+3,983
| +29% | +$106K | ﹤0.01% | 2292 |
|
|
2024
Q1 | $530K | Buy |
13,828
+2,472
| +22% | +$120K | ﹤0.01% | 2189 |
|
|
2023
Q4 | $764K | Buy |
11,356
+2,782
| +32% | +$194K | ﹤0.01% | 1995 |
|
|
2023
Q3 | $642K | Buy |
8,574
+884
| +11% | +$78.4K | ﹤0.01% | 1994 |
|
|
2023
Q2 | $709K | Buy |
7,690
+512
| +7% | +$45.6K | ﹤0.01% | 1974 |
|
|
2023
Q1 | $745K | Sell |
7,178
-63
| -0.9% | -$6.98K | ﹤0.01% | 1922 |
|
|
2022
Q4 | $835K | Buy |
7,241
+388
| +6% | +$45.2K | ﹤0.01% | 1864 |
|
|
2022
Q3 | $743K | Sell |
6,853
-557
| -8% | -$79.8K | ﹤0.01% | 1919 |
|
|
2022
Q2 | $1.34M | Sell |
7,410
-1,676
| -18% | -$300K | ﹤0.01% | 1756 |
|
|
2022
Q1 | $1.55M | Buy |
9,086
+349
| +4% | +$65.8K | ﹤0.01% | 1802 |
|
|
2021
Q4 | $1.83M | Sell |
8,737
-215
| -2% | -$44.4K | ﹤0.01% | 1752 |
|
|
2021
Q3 | $1.73M | Sell |
8,952
-1
| -0% | -$246 | ﹤0.01% | 1797 |
|
|
2021
Q2 | $2.53M | Sell |
8,953
-265
| -3% | -$71.8K | ﹤0.01% | 1656 |
|
|
2021
Q1 | $1.95M | Sell |
9,218
-1,308
| -12% | -$313K | ﹤0.01% | 1732 |
|
|
2020
Q4 | $2.07M | Sell |
10,526
-1,462
| -12% | -$258K | ﹤0.01% | 1624 |
|
|
2020
Q3 | $1.97M | Buy |
11,988
+1,872
| +19% | +$308K | ﹤0.01% | 1555 |
|
|
2020
Q2 | $1.4M | Sell |
10,116
-2,510
| -20% | -$230K | ﹤0.01% | 1657 |
|
|
2020
Q1 | $789K | Sell |
12,626
-2,095
| -14% | -$191K | ﹤0.01% | 1800 |
|
|
2019
Q4 | $1.61M | Buy |
14,721
+434
| +3% | +$42K | ﹤0.01% | 1684 |
|
|
2019
Q3 | $1.48M | Buy |
14,287
+50
| +0.4% | +$5.37K | ﹤0.01% | 1659 |
|
|
2019
Q2 | $1.83M | Buy |
14,237
+31
| +0.2% | +$4.31K | ﹤0.01% | 1621 |
|
|
2019
Q1 | $1.81M | Buy |
14,206
+8,068
| +131% | +$1.02M | ﹤0.01% | 1623 |
|
|
2018
Q4 | $767K | Buy |
6,138
+192
| +3% | +$32.8K | ﹤0.01% | 1913 |
|
|
2018
Q3 | $1.32M | Buy |
5,946
+2,278
| +62% | +$462K | ﹤0.01% | 1759 |
|
|
2018
Q2 | $587K | Buy |
3,668
+17
| +0.5% | +$2.17K | ﹤0.01% | 2067 |
|
|
2018
Q1 | $341K | Buy |
3,651
+21
| +0.6% | +$1.57K | ﹤0.01% | 2234 |
|
|
2017
Q4 | $253K | Hold |
3,630
| – | – | ﹤0.01% | 2340 |
|
|
2017
Q3 | $216K | Buy |
+3,630
| New | +$181K | ﹤0.01% | 2390 |
|
|
2016
Q3 | – | Sell |
-6,730
| Closed | -$224K | – | 2549 |
|
|
2016
Q2 | $224K | Buy |
+6,730
| New | +$217K | ﹤0.01% | 2285 |
|
Other funds holding MED
SCP
VCM
